In addition, TAMs can secrete various immunosuppressive mediators, such as interleukin-10 (IL-10), transforming growth factor-beta (TGF-β), and prostaglandin E2 (PGE2), into the TME to further inhibit anti-tumor immunity (Zhou et al., 2021). This evidence concerns the gene IL10 and neoplasm.